Prognostic Factors and Risk Stratification in Patients With Castration-Resistant Prostate Cancer Receiving Docetaxel-based Chemotherapy

Shimpei Yamashita; Yasuo Kohjimoto; Takashi Iguchi; Hiroyuki Koike; Hiroki Kusumoto; Akinori Iba; Kazuro Kikkawa; Yoshiki Kodama; Nagahide Matsumura; Isao Hara


BMC Urol. 2016;16(13) 

In This Article


Age, serum PSA level at the start of chemotherapy, and Hb were identified as independent prognostic factors of OS, and ECOG PS and the CRP-to-albumin ratio were not significant but were considered as possible predictors for OS in Japanese CRPC patients treated with docetaxel. Risk stratification based on these factors could be helpful for estimating OS.